| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.7M | — | -45.0% |
| Cost of Revenue | $1.1M | — | -69.4% |
| Gross Profit | $1.6M | — | +22.6% |
| R&D Expense | $424K | — | +0.0% |
| SG&A Expense | $4.8M | — | +99.4% |
| Operating Income | -$3.6M | — | -102.9% |
| Pre-tax Income | -$3.5M | — | -67.9% |
| Net Income | -$3.5M | — | -67.9% |
| EPS (Basic) | -$0.15 | — | +16.7% |
| EPS (Diluted) | -$0.15 | — | +16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $2.5M | +247.6% | +1080.2% |
| Inventory | $307K | +0.0% | -41.0% |
| Current Assets | $41.4M | +79.2% | +454.0% |
| Total Assets | $122.9M | +93.8% | +260.6% |
| Current Liabilities | $12.2M | +9.7% | -12.8% |
| Total Liabilities | $16.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | +70.9% |
| Investing Cash Flow | -$41.2M | — | -6981.8% |
| Financing Cash Flow | $60.1M | — | +2056.0% |
| -44.6% |
| Stockholders' Equity | $106.9M | +120.1% | +1974.5% |